Funded Tech Companies
Peptimmune
Peptimmune is a leading biopharmaceutical tech venture, located in Cambridge. Financial backing was provided by Vanguard Ventures, New Enterprise Associates and Prism VentureWorks.
Company Overview
Company Name
Peptimmune
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
64 Sidney Street 380
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Peptimmune is a clinical stage biotechnology company that is utilizing both novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2009
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Fredric Price
Chief Executive Officer
Thomas Mathers
VP - R & D
Eric Zanelli
VP - Regulatory Affairs
Uday Patel
Company Investors
- Vanguard Ventures
- New Enterprise Associates (James Barrett)
- Prism VentureWorks
- MPM Capital (Luke Evnin)
- Covera Ventures
- Silicon Valley Bank
- Itochu Corporation
- Vanguard Ventures (Hugh Rienhoff)
- Prism VentureWorks (John Brooks)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs